Navigation Links
Canmedical Secures AsepticSure Distribution Rights For Canadian Veterinary Market
Date:1/25/2012

SAN FRANCISCO, Jan. 25, 2012 /PRNewswire/ -- Medizone International, Inc. (MZEI:OB) (MZEI:QB) and Canmedical, a privately owned Canadian medical and veterinarian supply company, jointly announce the signing of a detailed Letter of Understanding in which a new division of Canmedical will become an AsepticSure distributor.

Canmedical and Reliance Associates LLC have formed a joint venture to establish, fund and operate throughout Canada.  Registration of the new division, tentatively named Contamination Control Company, will be incorporated in Ontario.

Under the agreement, this new division of Canmedical will have exclusive rights to the National Canadian Veterinary Market for AsepticSure.  Additionally, Canmedical currently has a client base of fifty hospitals in Ontario and will also retain the rights to that market.

Canmedical will begin to represent AsepticSure immediately, beginning with the Ontario Veterinary Medical Association Conference, January 26, 27 and 28 in Toronto.

The OVMA convention is being held at the Westin Harbour Castle, Toronto. Medizone CEO, Edwin Marshall, and Medizone President and Director of Medical Affairs, Dr Michael E. Shannon, will be present at the convention to help support this new venture by Canmedical.

Mr. Marshall commented, "This agreement signifies a joint effort to reduce the spread of infectious animal diseases within exotic veterinary practices, zoos, animal laboratories, animal feed and transportation settings, as well as the large animal and equine. The business plan, enthusiasm and intelligence that we've seen from Canmedical in their approach has been impressive. 

"I have no doubt that this new division of Canmedical will play a major role in decontamination and infectious disease control where animals are concerned. It's a venture destined for significant success."

As part of the agreement with Medizone, Canmedical has committed to an initial order of four AsepticSure systems for delivery in Q2.

Canmedical CEO Bob Simpson stated, "AsepticSure provides a perfect fit for Canmedical and will undoubtedly be embraced by the veterinary world in Canada. As a contamination control technology AsepticSure has no equal, hence the reason we chose to establish a dedicated division of our business just to accommodate what we firmly believe will be 'explosive growth' in the demand for AsepticSure, both in the vet industry and hospital and health care sector. We're proud and excited to form this venture with Medizone International and can see unlimited potential going forward."

For information on Canmedical, please contact:

Bob Simpson 001-613-358-5658     E: bob@canmedical.ca

Canmedical has been serving the Canadian hospital and vet industry, nationwide, for more than 25 yrs. Specializing in the supply, service and support of state-of-the-art digital ultrasound, autoclave and radiography equipment, Canmedical has become a national authority in the veterinary and hospital supplies field.

For press information on Medizone International, please contact:

Bruce Smeaton, Investor Relations, Medizone International, Inc.

T: 001-415-331-0202     E: bruce@medizoneint.com

Medizone International, Inc. is engaged in initial production of its modular design AsepticSure™ Decontamination Systems. Decontamination to the sterilization standard of >6 log (99.9999%) is obtainable within hospitals, airlines, cruise ships, long term care facilities, food processing plants, clean room manufacturing facilities, schools and other critical infrastructure. A government variant is being tested for bio-terrorism counter measures for building remediation.

This Press Release may contain certain forward looking statements that could involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

For more information, visit: www.medizoneint.com

Email: operations@medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. EntreMed Secures $10 Million Strategic Financing
2. Criticare Secures Contract to Supply nGenuity Vital Signs Monitors to Russian Hospitals
3. GlySure Secures $10.9 Million in Series C Financing Round
4. PharmacoFore, Inc. Secures $10 Million in Equity Financing From Founders Fund
5. AuraSense Therapeutics Secures Series B Equity Investment
6. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
7. ACT Secures First Patent for Generating Hemangioblast Cells to Treat a Broad Spectrum of Vascular and Hematopoietic Disorders
8. Awarepoint Corporation Secures $27 Million in New Financing: Kleiner Perkins Caufield & Byers Leads Round
9. NeurogesX, Inc. Secures $20 Million Debt Facility
10. Bacterin Secures $15 Million Credit Facility with MidCap Financial and Silicon Valley Bank
11. SurgiQuest, Inc. Secures $19 Million to Fund Commercialization and Launch the Next Generation Access Technology Cited by Surgeons as The Future of Minimally Invasive Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... -- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of ... announced results for its fiscal year and fourth quarter ... --> GAAP results: Revenue for the fourth quarter ... 4.1% from the third quarter of 2015, and up ... 2014. Revenue for the year ended December 31, 2015 was ...
(Date:2/4/2016)... 2016  Blueprint Medicines Corporation (NASDAQ: BPMC ... selective investigational kinase medicines for patients with genomically ... board of directors of Lonnel Coats , ... of industry-related experience. Jeffrey Albers ... strong strategic experience developing and commercializing numerous oncology ...
Breaking Medicine Technology:
(Date:2/6/2016)... ... 2016 , ... Research has shown that building shame resilience ... and level of relapse. , At the 2016 iaedp Symposium, the ... the critical tasks of the recovery phase and beyond including relapse prevention and ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the ... a variety of colors, assortments and packaging. This staple for Valentine’s Day is a ... location. , For Valentine’s Day, not only are long-stem roses available, but also ...
(Date:2/5/2016)... City, UT (PRWEB) , ... February 05, 2016 , ... ... Whole-Food Nutrition , announced that the much-anticipated feature with author Jahnavi Foster, specialist in ... Humans Amateur TV Network. , Each week, on his weekly Whole-Food Warrior TV show, ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... Santa Rosa, CA (PRWEB) , ... February 05, ... ... are pleased to announce the addition of micro-needling services in their Napa Valley ... appearance. The founders of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are ...
Breaking Medicine News(10 mins):